Ribonova
2 known investors
Ribonova is a biopharmaceutical company discovering and developing novel small-molecule medicines for patients with serious rare diseases. Its lead candidate, R007, is a Phase-2-ready treatment for inherited mitochondrial disease.
BiotechMedical Devices